403 related articles for article (PubMed ID: 25876646)
1. Identifying and targeting tumor-initiating cells in the treatment of breast cancer.
Wei W; Lewis MT
Endocr Relat Cancer; 2015 Jun; 22(3):R135-55. PubMed ID: 25876646
[TBL] [Abstract][Full Text] [Related]
2. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.
Dandawate PR; Subramaniam D; Jensen RA; Anant S
Semin Cancer Biol; 2016 Oct; 40-41():192-208. PubMed ID: 27609747
[TBL] [Abstract][Full Text] [Related]
3. DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor-Positive Breast Cancer Following Endocrine Therapy.
Peiffer DS; Wyatt D; Zlobin A; Piracha A; Ng J; Dingwall AK; Albain KS; Osipo C
Cancer Res; 2019 Oct; 79(19):4965-4977. PubMed ID: 31387918
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer.
Stratford AL; Reipas K; Maxwell C; Dunn SE
Expert Rev Mol Med; 2010 Jul; 12():e22. PubMed ID: 20653987
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of breast cancer stem cells: potential clinical applications.
Nguyen NP; Almeida FS; Chi A; Nguyen LM; Cohen D; Karlsson U; Vinh-Hung V
Cancer Treat Rev; 2010 Oct; 36(6):485-91. PubMed ID: 20231058
[TBL] [Abstract][Full Text] [Related]
7. Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications.
Izrailit J; Reedijk M
Cancer Lett; 2012 Apr; 317(2):115-26. PubMed ID: 22123293
[TBL] [Abstract][Full Text] [Related]
8. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
9. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
Liang ZM; Chen Y; Luo ML
Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
[TBL] [Abstract][Full Text] [Related]
10. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer stem cells: Biology and therapeutic implications.
Butti R; Gunasekaran VP; Kumar TVS; Banerjee P; Kundu GC
Int J Biochem Cell Biol; 2019 Feb; 107():38-52. PubMed ID: 30529656
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cell in breast cancer therapeutic resistance.
Bai X; Ni J; Beretov J; Graham P; Li Y
Cancer Treat Rev; 2018 Sep; 69():152-163. PubMed ID: 30029203
[TBL] [Abstract][Full Text] [Related]
13. Tumor senescence and radioresistant tumor-initiating cells (TICs): let sleeping dogs lie!
Zafarana G; Bristow RG
Breast Cancer Res; 2010; 12(4):111. PubMed ID: 20619004
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer stem cells: current advances and clinical implications.
Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
[TBL] [Abstract][Full Text] [Related]
16. The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches.
Lacerda L; Pusztai L; Woodward WA
Drug Resist Updat; 2010; 13(4-5):99-108. PubMed ID: 20739212
[TBL] [Abstract][Full Text] [Related]
17. Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer.
Kondratyev M; Kreso A; Hallett RM; Girgis-Gabardo A; Barcelon ME; Ilieva D; Ware C; Majumder PK; Hassell JA
Oncogene; 2012 Jan; 31(1):93-103. PubMed ID: 21666715
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells: the promise and the potential.
Ajani JA; Song S; Hochster HS; Steinberg IB
Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.
Qureshi-Baig K; Ullmann P; Haan S; Letellier E
Mol Cancer; 2017 Feb; 16(1):40. PubMed ID: 28209178
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]